abagovomab 48
abciximab 41
abituzumab 32
abrilumab 29
actoxumab 31
adalimumab 22
aducanumab 19
afasevikumab 24
alacizumab_pegol 16
alemtuzumab 39
alirocumab 25
amatuximab 56
andecaliximab 32
anifrolumab 32
anrukinzumab 25
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 28
ascrinvacumab 18
atezolizumab 16
atinumab 22
avelumab 20
basiliximab 52
bavituximab 51
begelomab 40
benralizumab 37
bevacizumab_beta 28
bezlotoxumab 31
bimagrumab 29
bleselumab 28
blinatumomab 51
blosozumab 36
bococizumab 31
brazikumab 22
brentuximab_vedotin 45
briakinumab 22
brodalumab 30
brolucizumab 32
brontictuzumab 31
burosumab 30
cabiralizumab 34
camrelizumab 17
canakinumab 30
cantuzumab_ravtansin 58
carlumab 24
carotuximab 34
cergutuzumab_amunaleukin2 39
cergutuzumab_amunaleukin 39
certolizumab_pegol 28
cetiximab 55
citatuzumab_bogatox 31
cixutumumab 38
clivatuzumab_tetraxetan 36
codrituzumab 37
conatumumab 21
concizumab 35
crenezumab 25
crizanlizumab 33
crotedumab 25
dacetuzumab 26
daclizumab 25
dalotuzumab 48
dapirolizumab_pegol 31
daratumumab 18
dectrekumab 14
demcizumab 37
denosumab 12
depatuxizumab 35
depatuxizumab_mafodotin 35
dezamizumab 30
dinutuximab 47
diridavumab 35
domagrozumab 20
drozitumab 28
duligotuzumab 21
durvalumab 19
dusigitumab 35
efalizumab 38
efungumab 35
eldelumab 25
elezanumab 33
elgemtumab 15
elotuzumab 23
emactuzumab 32
emapalumab 32
emibetuzumab 31
enavatuzumab 29
enfortumab_vedotin 16
enoblituzumab 23
enokizumab 32
enoticumab 25
ensituximab 47
eptinezumab 21
erenumab 30
etaracizumab 19
etrolizumab 25
evinacumab 26
evolocumab 30
farletuzumab 17
fasinumab 32
fezakinumab 33
fibatuzumab 25
ficlatuzumab 34
firivumab 42
flanvotumab 31
fletikumab 40
foralumab 21
foravirumab 19
fremanezumab 35
fresolimumab 29
fulranumab 25
futuximab 42
galcanezumab 26
ganitumab 36
gantenerumab 18
gemetuzumab 40
gemtuzumab2 37
gemtuzumab 38
gevokizumab 32
girentuximab 37
glembatumumab 29
glembatumumab_vedotin 29
guselkumab 30
ibalizumab 37
ibritumomab 51
icrucumab 20
idarucizumab 44
ifabotuzumab 25
imalumab 19
imgatuzumab 32
inclacumab 26
indatuximab_ravtansin 45
indusatumab 26
inebilizumab 34
intetumumab 23
iodine_girentuximab 34
ipilimumab 12
iratumumab 21
isatuximab 46
itolizumab 31
ixekizumab 40
labetuzumab_govitecan 29
lambrolizumab 36
lampalizumab 33
lanadelumab 21
landogrozumab 21
laprituximab 37
lebrikizumab 44
lendalizumab 32
lenzilumab 27
lifastuzumab_vedotin 27
ligelizumab 34
lilotomab 50
lirilumab 33
lodelcizumab 27
lokivetmab 29
lorvotuzumab_mertansin 30
lucatumumab 33
lumretuzumab 30
lupartumab 20
lutikizumab 23
margetuximab 46
milatuzumab 51
mirvetuximab 48
mirvetuximab_soravtansin 48
modotuximab 54
mogamulizumab 37
monalizumab 34
motavizumab 45
moxetumomab_pasudotox 35
namilumab 36
naratuximab 40
naratuximab_emtansin 40
narnatumab 25
navicixizumab2 33
navicixizumab 38
navivumab 44
necitumumab 20
nemolizumab 35
nesvacumab 21
nivolumab 21
obiltoxaximab 29
obinutuzumab 39
ocaratuzumab 35
ofatumumab 24
olaratumab 29
olokizumab 28
omalizumab 23
onartuzumab 27
ontuxizumab 38
opicinumab 18
orticumab 17
otelixizumab 44
oxelumab 15
ozanezumab 42
pamrevlumab 15
panobacumab 32
parsatuzumab 32
pasotuxizumab 23
pateclizumab 23
patritumab 32
pembrolizumab 36
perakizumab 27
pidilizumab 31
pinatuzumab_vedotin 20
plozalizumab 34
pogalizumab 33
polatuzumab_vedotin 25
ponezumab 47
prezalumab 18
pritoxaximab 55
quilizumab 23
racotumomab 42
radretumab 20
ralpancizumab 33
ramucirumab 17
ranevetmab 37
ranibizumab 28
refanezumab 33
remtolumab 21
rilotumumab 31
rinucumab 29
risankizumab 43
rituximab 35
rivabazumab 28
robatumumab 22
roledumab 37
romosozumab 34
rontalizumab 27
rosmantuzumab 35
rozanolixizumab 30
sacituzumab 41
sacituzumab_govitecan 41
samalizumab 32
sapelizumab 26
sarilumab 20
secukinumab 25
seribantumab 20
setoxaximab 57
sifalimumab 28
siltuximab 37
simtuzumab 35
sirukumab 19
solanezumab 29
solitomab 39
stamulumab 31
suptavumab 33
suvizumab 29
tabalumab 27
tadocizumab 25
tamtuvetmab 40
tanezumab 31
tarextumab 16
tavolixizumab 28
telisotuzumab 39
teplizumab 29
tesidolumab 39
tezepelumab 35
tigatuzumab 20
tildrakizumab 30
timolumab 21
tisotumab 18
tosatoxumab 46
tositumomab 48
tralokinumab 44
trastuzumab 25
tregalizumab 26
trevogrumab 18
ublituximab 42
urelumab 34
ustekinumab 35
utomilumab 39
vadastuximab 39
vadastuximab_talirin 39
vandortuzumab_vedotin 25
vantictumab 32
vanucizumab2 28
vanucizumab 45
varlilumab 20
vatelizumab 31
vedolizumab 42
veltuzumab 28
vesencumab 14
vorsetuzumab 32
vorsetuzumab_mafodotin 32
vunakizumab 50
xentuzumab 23
zatuximab 54
